Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and Denmark
Henriksson M, Nikolic E, Ohna A, Wallentin L, Janzon M
Record Status
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Bibliographic details
Henriksson M, Nikolic E, Ohna A, Wallentin L, Janzon M. Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and Denmark. Scandinavian Cardiovascular Journal 2014; 48(3): 138-147